Previous 10 | Next 10 |
Deloitte Unveils 2021 North America Technology Fast 500 Rankings California-based global medical technology company claims top spot in 27th annual ranking of fastest-growing businesses PR Newswire SAN FRANCISCO , Nov. 17, 2021 /PRNewswire/ -- Deloitte today r...
Axonics, Inc. (AXNX) Q3 2021 Earnings Conference Call November 4, 2021 16:30 ET Company Participants Neil Bhalodkar - Vice President of Investor Relations Raymond Cohen - Chief Executive Officer & Director Dan Dearen - President & Chief Financial Officer Conference Call Participants A...
Image source: The Motley Fool. Axonics Modulation Technologies Inc (NASDAQ: AXNX) Q3 2021 Earnings Call Nov 4, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Axonics Modulation Technologies Inc (AXNX) Q3 2021 Earni...
Gainers: Ontrak (NASDAQ:OTRK) +29%. BigCommerce Holdings (NASDAQ:BIGC) +17%. Farmer Brothers Company (NASDAQ:FARM) +17%. JFrog (NASDAQ:FROG) +13%. Expedia Group (NASDAQ:EXPE) +11%. Losers: Peloton Interactiv (NASDAQ:PTON) -26%. Applied Optoelectronics (NASDA...
Axonics Modulation Technologies (NASDAQ:AXNX): Q3 GAAP EPS of -$0.38 beats by $0.05. Revenue of $46.91M (+33.1% Y/Y) misses by $1.48M. Shares -8.08%. Press Release For further details see: Axonics Modulation Technologies EPS beats by $0.05, misses on revenue
Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today reported financial results for the third quarter ended September 30, 2021. “We are pleased with th...
Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, has been named by the Orange County Business Journal as the fastest growing publicly traded company in Orange C...
Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, will report third quarter 2021 financial results after the market closes on Thursday, November 4, 2021. In conj...
Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has issued fi...
Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has issued fi...
News, Short Squeeze, Breakout and More Instantly...
Axonics Modulation Technologies Inc. Company Name:
AXNX Stock Symbol:
NASDAQ Market:
Axonics Modulation Technologies Inc. Website:
Axonics, Inc. (NASDAQ: AXNX) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 0.09% on the day to $68.5. Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulat...
Generated record revenue, gross margin and net income in 2Q24 Axonics, Inc. (Nasdaq: AXNX), a medical technology company that develops, manufactures and commercializes innovative and minimally invasive products to treat bladder and bowel dysfunction, today reported financial results f...
Viridien ADR (CGGYD) is expected to report for Q2 2024 Civitas Resources Inc. (CIVI) is expected to report $2.9 for Q2 2024 Aptiv PLC (APTV) is expected to report $1.37 for Q2 2024 Ardelyx Inc. (ARDX) is expected to report $-0.1 for Q2 2024 Beazer Homes USA Inc. (BZH) is expected ...